TCL Archive IDMC Recommends Halting Phase III Trial Of Onartuzumab in MET-Positive NSCLC March 28, 2014
TCL Archive Breast Cancer Coalition Widens Its Agenda For Advocacy, Vows To Fight NIH Cutbacks May 5, 1995